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A 47-year-old female presented to clinic with a 5-year history of a left buttock mass. The
patient's hemoglobin was low (9.7 g/dL); laboratory analysis was otherwise unremarkable.
Ultrasound of the left gluteal region demonstrated a heterogeneous vascular solid lesion.
Magnetic resonance and computed tomography imaging showed an enhancing mass
extending from the left ischioanal fossa through the levator ani muscle into the pelvis.
Biopsy revealed bland-appearing spindle-shaped cells positive for estrogen and proges-
terone receptors, consistent with an aggressive angiomyxoma. The mass was surgically
excised without complication. To date, follow-up imaging has not demonstrated evidence
of tumor recurrence.
© 2016 the Authors. Published by Elsevier Inc. under copyright license from the University
of Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Aggressive angiomyxomas are raremesenchymal tumors that
occur predominantly in females of reproductive age, with
peak incidence typically in the 4th to 5th decades of life [1,2].
Patients are often asymptomatic at the time of diagnosis, with
perineal or vulvar masses discovered incidentally during
physical examination or radiologic imaging [1]. Although rare,
aggressive angiomyxomas exhibit typical patterns on ultra-
sound, CT, and MR imaging: tumors nearly always occur
within the perineal and/or pelvic region, and on MRI charac-
teristically demonstrate a “swirled” appearance of relativelyN. have no disclosure.
blication elsewhere. All a
Benson).
Elsevier Inc. under copy
se (http://creativecommolow-intensity internal stranding on both T1- and T2-weighted
images [3e5]. Here, a case of aggressive angiomyxoma and
corresponding review of the literature is presented, with the
aim to familiarize clinicians with the clinical and imaging
characteristics of these tumors.Case report
On review of systems during a clinic visit, a 47-year-old female
with poor priormedical care but otherwise unremarkable past
medical history noted a 5-year history of a left buttock massuthors have participated sufficiently to take public responsibility
right license from the University of Washington. This is an open
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Fig. 1 e Ultrasound of the left gluteal region demonstrates a circumscribed, predominantly hypoechoic mass (A). Color
Doppler evaluation of the mass reveals significant internal vascularity (B). The visualized portions of the mass measured
approximately 6 cm in transverse dimensions; the intra-pelvic involvement of the mass was not detected sonographically.
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examination, a firm and nontender mass was palpated in the
left gluteal region. The patient's hemoglobinwas low (9.7 g/dL);
a comprehensive laboratory analysis that included complete
blood count and basic metabolic panel and hepatic panel was
otherwiseunremarkable. Ultrasoundof the palpablemasswas
performed, which demonstrated a predominantly hypoechoic
circumscribed solid lesionwith internal blood flow (Fig. 1). The
patient subsequently underwent CT (Fig. 2) and MRI (Fig. 3),
which revealed an enhancingmasswithin left ischioanal fossa
that extended through the pelvic floor musculature into the
pelvis. The lesion displaced, but did not infiltrate, the urinary
bladder and uterus. On MRI, the mass demonstrated
concentric linear bands of T1 and T2 signal in a “swirled”
pattern (Fig. 3). Incisional biopsy of the mass demonstrated
bland-appearing spindle-shaped cells positive for estrogen
and progesterone receptors, consistent with an aggressive
angiomyxoma (Fig. 4). The patient underwent surgical
excision of the mass approximately 3 weeks after her initial
clinic visit (Fig. 4). Follow-up CT imaging has demonstrated
disease-free status for 1 year.Discussion
Aggressive angiomyxomas are rare tumors that typically
occur in adult women, with a peak incidence between 30 andFig. 2 e Coronal (A) and axial (B) contrast-enhanced CT of the pelv
side of the pelvis and has relatively circumscribed margins. Th
urinary bladder (curved arrows) and uterus (thick arrows).50 years [1,2]. Female to male ratio is 6.6:1 [6]. The tumors
most commonly occur within the perineal and/or pelvic
region [3]. On sonographic imaging, aggressive angiomyx-
omas typically appear as a hypoechoic or cystic mass [7]. CT
imaging typically demonstrates a mass with well-defined
margins, slightly hypodense to muscle [8]. On MRI, these
tumors are usually hyperintense on T2-weighted images,
likely related to high water content and loose myxoid matrix
[4,5,9]. On T1-weighted images, the tumors are isointense to
muscle [4,5,9]. Characteristically, the mass will have internal
areas of “swirled” linear low-intensity signal on both
T1-weighted and T2-weighted images, thought to be related
to the fibrovascular stroma [4,5,9]. The “swirled” appearance
is less frequently appreciated on contrast-enhanced CT
[4,5]. Aggressive angiomyxomas demonstrate significant
contrast enhancement, likely due to the high internal
vascularity [5].
On gross evaluation, the tumors are tan-gray to pink and
have a rubbery consistency with a gelantinous and glistening
cut surface [7]. Histologically, aggressive angiomyxomas are
sparsely cellular, composed of spindle and stellate-shaped cells
on a soft myxoid background [1,6e8]. Internal blood vessels
characteristically demonstrate variable caliber and/or wall
thickness; some vessels have thick, muscular walls whichmay
be hyalinized [7,10]. Resectionmargins are often positive due to
the tumor's proclivity to infiltrate local tissues [1]. Cells stain
positive for estrogen and progesterone receptors as well asis. Themass (thin straight arrows) is located within the left
e tumor causes mass effect on, but does not invade, the
Fig. 3 e Axial contrast-enhanced T1 fat saturated images of the perineum (A) and pelvis (B), coronal T2-weighted fat
saturated image (C), and axial proton density weighted image (D) of the pelvis. The tumor is seen extending from the left
ischioanal fossa (thin arrow, (A)), through the levator ani muscle, into the pelvis (thin arrows, (B), (C), and (D)). The mass
demonstrates marked enhancement and has internal low-intensity “swirled” signal on all image sequences. Adjacent
structures, including the urinary bladder (curved arrows) and uterus (thick arrow), are shifted to the right but are not
invaded by the tumor.
Fig. 4 e Gross pathology (A), H&E stained sections ((B) and (C)), and progesterone stained section (D) of the tumor. Gross
evaluation demonstrates a lobulated mass with a tan-gray and pink surface; normal yellow fat (arrows in (A)) is noted along
the periphery. Histologically, the tumor is composed of a uniform distribution of bland-appearing spindle-shaped cells (B),
with local invasion of the adjacent fat (asterisks). The lesion is highly vascular, with some blood vessels showing
characteristic thickened walls (between straight arrows, (C)) and hyalinization surrounding the vessel walls (curved arrow,
(C)). The tumor stained positive for both progesterone (D) and estrogen (not shown) receptors.
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cytokeratins are usually negative [1,2,4,7].
The main differential consideration for aggressive angio-
myxomas is angiomyofibroblastoma [11]. The tumor's size is a
useful differentiating factor: angiomyofibroblastomas tend to
be small and affect only the superficial vulva and vagina,
whereas aggressive angiomyxomas are often large masses
involving the deep tissues planes at the time of diagnosis [12].
Myxomas andmyxoid liposarcomas are also considered as part
of the differential. However, myxomas are located intramus-
cularly, whereas aggressive angiomxyomas may abut, but do
not invade, the pelvic and/or perinealmusculature [12]. Myxoid
liposarcomas more commonly occur within the lower extrem-
ities, demonstrate lacy or linear internal fat, andhomogenously
enhance [12]. Aggressive angiomyxomas, conversely, lack
significant internal fat and enhance heterogeneously [5,12].
Treatment of aggressive angiomxyomas involves wide
local surgical excision [5,8,13]. Hormonal therapy, including
raloxifene, tamoxifen, and gonadotropin-releasing hormone
analogs, is also used to both shrink the tumor before excision
and treat recurrences [5,12]. Chemotherapy and radiation are
generally considered to be poor treatment options due to the
tumor's low mitotic activity [8]. In addition, embolization is
usually not used as the tumors frequently have numerous
feeding vessels [11].
Although aggressive angiomyxomas are benign, local
recurrence is quite common; “aggressive” was added as a
prefix to the classification of these tumors to emphasize their
infiltrative nature and tendency to recur [6,7,14]. In 1 case
study of 73 subjects, 34 of 73 (47%) developed recurrent dis-
ease, with the rate of recurrence noted to be similar among
patients with and without clear resection margins [6]. A few
exceptionally rare cases have also been reported of metastatic
aggressive angiomxyomas, including cases in which the
patients succumbed to the disease [15]. Hence, long-term
follow-up is recommended after surgical excision [6]. Never-
theless, prognosis is generally quite good [15].Acknowledgment
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